(Q47734769)

5 February 2018

meta-analysis

0 references

title

Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis? (English)

1 reference

5 February 2018

0 references

9

1 reference

5 February 2018

author name string

Mathurin P

1

1 reference

5 February 2018

Rixe O

2

1 reference

5 February 2018

Carbonell N

3

1 reference

5 February 2018

Bernard B

4

1 reference

5 February 2018

Cluzel P

5

1 reference

5 February 2018

Bellin MF

6

1 reference

5 February 2018

Khayat D

7

1 reference

5 February 2018

Opolon P

8

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 February 1998

1 reference

5 February 2018

Alimentary Pharmacology & Therapeutics

published in

1 reference

5 February 2018

volume

12

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

page(s)

111-126

1 reference

5 February 2018

A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG study

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma. Effects of serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Prospective and randomized controlled study of chemoembolization therapy in patients with advanced hepatocellular carcinoma. Cooperative Study Group for Liver Cancer Treatment in Shikoku area

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

5-Fluorouracil in hepatocellular carcinoma.Report of twenty-one cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Neocarzinostatin versus m-AMSA or doxorubicin in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

A randomized prospective trial comparing full dose chemotherapy to 131I antiferritin: An RTOG study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Primary liver cancer. An Eastern Cooperative Oncology Group Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Surgical resection and survival in Western patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Meta-analyses of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Methods for combining randomized clinical trials: strengths and limitations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Natural history of hepatocellular carcinoma in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection,

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

10.1046/J.1365-2036.1998.00286.X

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018